Analysts’ Updated EPS Estimates for June 17th (ADPT, AO, BBOX, BV, CML, COIN, CYTK, DOC, DUOL, EOLS)

Analysts’ updated eps estimates for Wednesday, June 17th:

Adaptive Biotechnologies (NASDAQ:ADPT) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $22.00 price target on the stock.

AO World (LON:AO) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 160 target price on the stock.

Tritax Big Box REIT (LON:BBOX) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 200 target price on the stock.

Oppenheimer Holdings, Inc. initiated coverage on shares of BrightView (NYSE:BV). Oppenheimer Holdings, Inc. issued an outperform rating and a $17.00 price target on the stock.

CML Microsystems (LON:CML) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Coinbase Global (NASDAQ:COIN) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $220.00 price target on the stock.

Coinbase Global (NASDAQ:COIN) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $280.00 price target on the stock.

Coinbase Global (NASDAQ:COIN) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $240.00 price target on the stock.

Coinbase Global (NASDAQ:COIN) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $270.00 target price on the stock.

Cytokinetics (NASDAQ:CYTK) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $102.00 target price on the stock.

Raymond James Financial, Inc. started coverage on shares of Healthpeak Properties (NYSE:DOC). They issued a market perform rating on the stock.

Duolingo (NASDAQ:DUOL) had its neutral rating reaffirmed by analysts at DA Davidson. They currently have a $120.00 target price on the stock.

Evolus (NASDAQ:EOLS) had its buy rating reissued by analysts at BTIG Research. They currently have a $13.00 price target on the stock.

Frontier IP Group (LON:FIPP) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

Sanford C. Bernstein began coverage on shares of Fervo Energy (NASDAQ:FRVO). They issued an outperform rating and a $47.00 price target on the stock.

Games Workshop Group (LON:GAW) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a £218.50 price target on the stock.

Haemonetics (NYSE:HAE) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $84.00 price target on the stock.

Huron Consulting Group (NASDAQ:HURN) had its outperform rating reissued by analysts at Barrington Research.

Prima BioMed (NASDAQ:IMMP) was upgraded by analysts at Maxim Group from a hold rating to a buy rating.

IQVIA (NYSE:IQV) had its equal weight rating reissued by analysts at Morgan Stanley. The firm currently has a $200.00 price target on the stock, down from their previous price target of $225.00.

Opus Genetics (NASDAQ:IRD) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $8.00 price target on the stock.

Leidos (NYSE:LDOS) had its neutral rating reiterated by analysts at Bank of America Corporation. The firm currently has a $125.00 target price on the stock, down from their previous target price of $200.00.

Lyft (NASDAQ:LYFT) was upgraded by analysts at Rothschild & Co Redburn from a neutral rating to a buy rating. They currently have $22.00 price target on the stock.

Macerich (NYSE:MAC) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. JPMorgan Chase & Co. currently has $25.00 price target on the stock, up from their previous price target of $23.00.

Medtronic (NYSE:MDT) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $101.00 price target on the stock.

Nexxen International (NASDAQ:NEXN) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $16.00 target price on the stock.

Phathom Pharmaceuticals (NASDAQ:PHAT) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $26.00 target price on the stock.

uniQure (NASDAQ:QURE) was upgraded by analysts at Cantor Fitzgerald from a neutral rating to an overweight rating. Cantor Fitzgerald currently has $61.00 price target on the stock.

Rathbones Group (LON:RAT) had its underperform rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 1,780 price target on the stock.

Rexford Industrial Realty (NYSE:REXR) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. The firm currently has $36.00 price target on the stock, down from their previous price target of $38.00.

SailPoint (NASDAQ:SAIL) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $19.00 target price on the stock.

SailPoint (NASDAQ:SAIL) had its overweight rating reissued by analysts at Stephens. They currently have a $20.00 price target on the stock.

SailPoint (NASDAQ:SAIL) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $23.00 price target on the stock.

Raymond James Financial, Inc. assumed coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA). They issued an underperform rating on the stock.

Smiths News (LON:SNWS) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 85 target price on the stock.

ServiceTitan (NASDAQ:TTAN) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $100.00 price target on the stock.

JonesTrading began coverage on shares of Tyra Biosciences (NASDAQ:TYRA). The firm issued a buy rating and a $56.00 price target on the stock.

Mizuho started coverage on shares of Western Midstream Partners (NYSE:WES). The firm issued an outperform rating and a $48.00 target price on the stock.

Wabash National (NYSE:WNC) was upgraded by analysts at DA Davidson from a neutral rating to a buy rating. DA Davidson currently has $20.00 target price on the stock.

Raymond James Financial, Inc. began coverage on shares of Global Medical REIT (NYSE:XRN). The firm issued a market perform rating on the stock.